How to Get Opdivo (nivolumab) Covered by UnitedHealthcare in North Carolina: Complete Appeals Guide with Forms and Timelines
Answer Box: Getting Opdivo Covered by UnitedHealthcare in North Carolina
UnitedHealthcare requires prior authorization for Opdivo (nivolumab) and may apply step therapy requirements. If denied, you can appeal through UnitedHealthcare's internal process, then request external review through North Carolina's Smart NC program within 120 days.
Your fastest path to approval:
- Submit complete prior authorization with FDA-approved indication, biomarker results (if required), and prior therapy documentation
 - If denied, request peer-to-peer review within 5 business days
 - File internal appeal with medical necessity letter citing NCCN guidelines
 - Request Smart NC external review if final denial occurs
 
Start today: Contact your oncologist to gather all treatment records and submit a complete PA request through the UnitedHealthcare Provider Portal.
Table of Contents
- Understanding UnitedHealthcare's Coverage Requirements
 - Reading Your Denial Letter
 - Common Denial Reasons and Quick Fixes
 - The Prior Authorization Process
 - Internal Appeals: Step-by-Step Guide
 - Peer-to-Peer Review Strategy
 - North Carolina External Review Process
 - Medical Necessity Letter Template
 - Costs and Financial Assistance
 - When to Escalate and File Complaints
 - Frequently Asked Questions
 
Understanding UnitedHealthcare's Coverage Requirements
UnitedHealthcare requires prior authorization for Opdivo (nivolumab) across most commercial plans, administered through OptumRx as of 2024. The insurer applies evidence-based criteria aligned with FDA-approved indications and NCCN guidelines.
Coverage Requirements at a Glance
| Requirement | What It Means | Where to Find It | Source | 
|---|---|---|---|
| Prior Authorization | Required for all Opdivo prescriptions | UnitedHealthcare Provider Portal | UHC PA Requirements | 
| Step Therapy | May require trying alternatives first | Plan-specific clinical criteria | OptumRx Guidelines | 
| Biomarker Testing | MSI-H/dMMR for CRC, EGFR/ALK exclusion for NSCLC | FDA label requirements | FDA Opdivo Label | 
| Medical Necessity | Must match FDA indication or NCCN guidelines | Clinical documentation | NCCN Guidelines | 
Reading Your Denial Letter
When UnitedHealthcare denies Opdivo coverage, your denial letter contains critical information for your appeal strategy. Look for these key elements:
Essential Information to Extract:
- Denial reason code (e.g., "not medically necessary," "step therapy required")
 - Appeal deadline (typically 180 days from denial date)
 - Required documentation for appeal
 - Contact information for appeals submission
 - Member/policy ID and claim number
 
Tip: Take a photo of your denial letter immediately. You'll reference it multiple times during the appeals process.
Common Denial Reasons and Quick Fixes
| Denial Reason | How to Overturn | Required Documents | 
|---|---|---|
| "Not medically necessary" | Submit medical necessity letter citing FDA indication and NCCN guidelines | Treatment history, pathology reports, NCCN excerpts | 
| "Step therapy required" | Document prior therapy failures or contraindications | Prior authorization denials, adverse event reports | 
| "Missing biomarker testing" | Submit required test results | MSI-H/dMMR results for CRC, EGFR/ALK testing for NSCLC | 
| "Wrong diagnosis code" | Verify ICD-10 codes match FDA-approved indications | Updated prescription with correct codes | 
| "Quantity limits exceeded" | Justify dosing per FDA label or clinical guidelines | Weight-based dosing calculations, clinical rationale | 
The Prior Authorization Process
Step-by-Step: Fastest Path to Approval
- Gather Required Documentation (Patient/Clinic)
- Complete diagnosis with staging and histology
 - Prior treatment history with dates and outcomes
 - Required biomarker results
 - Current performance status and labs
 - Timeline: 2-3 business days
 
 - Submit Complete PA Request (Prescriber)
- Use UnitedHealthcare Provider Portal
 - Include all supporting documentation
 - Timeline: Same day submission possible
 - Source: UHC Provider Portal
 
 - Await Initial Decision (UnitedHealthcare)
- Standard review: up to 14 days
 - Expedited review: 72 hours for urgent cases
 - Timeline: Varies by urgency
 
 - If Approved: Proceed with treatment
 - If Denied: Request peer-to-peer review within 5 business days
 
Clinician Corner: For expedited reviews, clearly document why delay would "seriously jeopardize life or ability to regain function" in your PA request.
Internal Appeals: Step-by-Step Guide
UnitedHealthcare offers a two-level internal appeals process before you can request external review in North Carolina.
Level 1 Internal Appeal
Deadline: 180 days from denial notice Response Time:
- Standard: 30 days
 - Expedited: 72 hours
 
Required Components:
- Completed appeal form or written request
 - Copy of denial letter
 - Medical necessity letter from prescriber
 - Supporting clinical documentation
 - Patient authorization for medical record release
 
Submission Options:
- Online: UnitedHealthcare member/provider portal
 - Fax: Number provided in denial letter
 - Mail: Address specified in denial notice
 
Level 2 Internal Appeal
If Level 1 is denied, you can request a second internal review. This follows the same process but is reviewed by different medical personnel, often including external clinical experts.
Peer-to-Peer Review Strategy
A peer-to-peer review allows your oncologist to speak directly with a UnitedHealthcare medical director about your case.
Scheduling Requirements
- Who can request: Only the prescribing physician
 - When to request: Within 5 business days of denial
 - How to schedule: Through provider portal or by calling OptumRx at 1-800-711-4555
 
Preparation Checklist for Physicians
- Complete patient timeline with treatment dates
 - NCCN guideline excerpts supporting Opdivo use
 - Documentation of prior therapy failures
 - Biomarker results (when applicable)
 - Patient's current functional status
 - Alternative treatment contraindications
 
Key Talking Points
- Specific FDA indication that matches patient's diagnosis
 - Prior therapy failures with objective evidence
 - NCCN guideline support for current treatment line
 - Patient-specific factors making alternatives unsuitable
 - Expected clinical benefit based on published data
 
North Carolina External Review Process
If UnitedHealthcare upholds their denial after internal appeals, North Carolina residents can request an independent external review through Smart NC.
Eligibility Requirements
- Completed UnitedHealthcare's internal appeals process
 - State-regulated insurance plan (most individual and small group plans qualify)
 - Denial based on medical necessity or experimental treatment determination
 - Request filed within 120 days of final internal denial
 
How to Request External Review
Contact Information: Health Insurance Smart NC
N.C. Department of Insurance
Phone: 1-855-408-1212
Mail: 1201 Mail Service Center, Raleigh, NC 27699-1201
Required Documents:
- Completed external review request form
 - Copy of final denial letter from UnitedHealthcare
 - Medical records supporting medical necessity
 - Signed authorization for medical record release
 
Timeline for External Review
| Review Type | Decision Timeline | When to Use | 
|---|---|---|
| Standard Review | 45 days from acceptance | Most cases | 
| Expedited Review | 4 business days | Life-threatening situations, urgent cancer treatment | 
Success Rate: North Carolina accepts approximately 61% of external review requests, making complete documentation crucial.
Medical Necessity Letter Template
[Date]
UnitedHealthcare Appeals Department
[Address from denial letter]
Re: Appeal for Opdivo (nivolumab) Coverage
Patient: [Name], DOB: [Date]
Member ID: [ID Number]
Claim Number: [Number]
Dear Medical Review Team,
I am appealing the denial of coverage for Opdivo (nivolumab) for my patient diagnosed with [specific cancer type, stage, and histology]. This treatment is medically necessary based on FDA-approved indications and NCCN guidelines.
**Clinical Justification:**
Patient Diagnosis: [Include ICD-10 code and complete staging]
Prior Treatment History:
- [List chronologically with dates, responses, and reasons for discontinuation]
- [Document objective progression or intolerance with supporting evidence]
FDA Indication: Opdivo is FDA-approved for [specific indication matching patient's diagnosis].
NCCN Guidelines: The [year] NCCN Guidelines recommend nivolumab as [preferred/recommended/alternative] therapy for patients with [diagnosis] who have [specific clinical scenario].
Biomarker Status: [Include required testing results - MSI-H/dMMR for CRC, EGFR/ALK status for NSCLC]
Medical Necessity: Given [patient-specific factors], standard therapies are contraindicated or have failed. Opdivo offers significant potential for clinical benefit based on [cite relevant clinical trial or real-world evidence].
Alternative Exclusions: [List contraindications to other treatments]
I request urgent reconsideration of this denial. Please contact me at [phone] with questions.
Sincerely,
[Physician Name, Credentials]
[NPI Number]
Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters, plan policies, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned with each payer's requirements. For complex cases like Opdivo appeals, they pull the right citations from FDA labeling, peer-reviewed studies, and specialty guidelines while ensuring all procedural requirements are met.
Costs and Financial Assistance
Opdivo's list price is approximately $7,943 per 240mg vial, with total regimen costs varying by cancer type and patient weight.
Financial Support Options
Bristol Myers Squibb Patient Assistance:
- Access Support: 1-800-721-8909
 - Copay assistance for eligible commercially insured patients
 - Free drug program for uninsured patients meeting income criteria
 
North Carolina Resources:
- CancerCare: Financial assistance and copay relief programs
 - Patient Advocate Foundation: Copay relief fund for cancer patients
 - North Carolina Cancer Fund: State-specific assistance programs
 
Note: Copay assistance programs typically cannot be combined with government insurance (Medicare, Medicaid).
When to Escalate and File Complaints
If you believe UnitedHealthcare is improperly denying coverage or not following required procedures, you can file complaints with regulatory authorities.
North Carolina Department of Insurance
Smart NC Consumer Assistance: 1-855-408-1212 When to contact:
- Improper denial of external review request
 - Failure to meet appeal deadlines
 - Procedural violations during appeals process
 
Federal Regulators
Department of Labor (ERISA plans): 1-866-444-3272 Centers for Medicare & Medicaid Services: 1-800-MEDICARE
Frequently Asked Questions
How long does UnitedHealthcare prior authorization take in North Carolina? Standard PA requests receive decisions within 14 days. Expedited reviews for urgent cancer cases are completed within 72 hours.
What if Opdivo is non-formulary on my plan? Non-formulary drugs can still be covered through the medical exception process. Submit a medical necessity letter documenting why formulary alternatives are inappropriate.
Can I request an expedited appeal? Yes, if delay in treatment would seriously jeopardize your health. Document the urgency in your appeal request and ask your oncologist to provide supporting clinical rationale.
Does step therapy apply if I failed similar treatments outside North Carolina? Yes, document all prior therapy attempts regardless of location. Include medical records showing treatment failures or adverse events.
What happens if Smart NC external review is denied? The external review decision is binding on UnitedHealthcare. If denied, explore alternative treatments, clinical trials, or manufacturer assistance programs.
How do I know if my plan is eligible for North Carolina external review? Most individual and small group plans are state-regulated and eligible. Self-funded employer plans may not be eligible unless the employer opted into North Carolina's system.
Can I submit additional information during the external review? Yes, you have up to 7 days after your request is accepted to submit additional supporting documentation to the Independent Review Organization.
What if UnitedHealthcare doesn't respond to my appeal within the required timeframe? Contact Smart NC at 1-855-408-1212 to report the delay. You may be able to proceed directly to external review.
From our advocates: "We've seen many Opdivo denials overturned when patients provide complete biomarker testing results and detailed documentation of prior therapy failures. The key is matching your clinical documentation exactly to the FDA indication and NCCN guidelines for your specific cancer type and treatment line. Don't assume the reviewer knows your medical history—spell out every detail."
For complex appeals requiring detailed policy analysis and evidence compilation, Counterforce Health provides specialized support in navigating insurance denials for cancer treatments, ensuring all procedural requirements are met while building the strongest possible case for coverage.
Sources & Further Reading
- UnitedHealthcare Prior Authorization Requirements (PDF)
 - OptumRx Prior Authorization Guidelines
 - FDA Opdivo (nivolumab) Prescribing Information
 - North Carolina Smart NC External Review Guide
 - UnitedHealthcare Provider Portal
 - Bristol Myers Squibb Opdivo Information
 
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan benefits and clinical circumstances. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For additional consumer assistance with insurance appeals in North Carolina, contact Smart NC at 1-855-408-1212.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.